arrow_back Back to App

Improved Access to Care for Primary Immunodeficiency Patients

This act aims to improve access to skilled nursing facilities for patients with primary immunodeficiency by ensuring that the costs of administering intravenous immune globulin are covered. This means individuals needing this therapy can receive it in nursing facilities, potentially improving their quality of life and access to essential treatment.
Key points
Patients with primary immunodeficiency will have better access to treatment in skilled nursing facilities.
Costs for administering intravenous immune globulin will be covered as part of services in these facilities.
The changes will take effect on January 1, 2024, allowing patients to benefit from the new rules from that date.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_3379
Sponsor: Rep. Matsui, Doris O. [D-CA-7]
Process start date: 2023-05-16
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

PI Post Acute Access Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_3379.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-05-16.

What are the main provisions?

Key points include:

  • Patients with primary immunodeficiency will have better access to treatment in skilled nursing facilities.
  • Costs for administering intravenous immune globulin will be covered as part of services in these facilities.
  • The changes will take effect on January 1, 2024, allowing patients to benefit from the new rules from that date.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Matsui, Doris O. [D-CA-7].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health Benefits